These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. Regadenoson pharmacologic rubidium-82 PET: a comparison of quantitative perfusion and function to dipyridamole. Cullom SJ; Case JA; Courter SA; McGhie AI; Bateman TM J Nucl Cardiol; 2013 Feb; 20(1):76-83. PubMed ID: 23188625 [TBL] [Abstract][Full Text] [Related]
33. Value of SiPM PET in myocardial perfusion imaging using Rubidium-82. Koenders SS; van Dalen JA; Jager PL; Knollema S; Timmer JR; Mouden M; Slump CH; van Dijk JD J Nucl Cardiol; 2022 Feb; 29(1):204-212. PubMed ID: 32410059 [TBL] [Abstract][Full Text] [Related]
34. Regadenoson versus dipyridamole: Evaluation of stress myocardial blood flow response on a CZT-SPECT camera. Brana Q; Thibault F; Courtehoux M; Metrard G; Ribeiro MJ; Angoulvant D; Bailly M J Nucl Cardiol; 2022 Feb; 29(1):113-122. PubMed ID: 32651801 [TBL] [Abstract][Full Text] [Related]
35. Incremental diagnostic value of regional myocardial blood flow quantification over relative perfusion imaging with generator-produced rubidium-82 PET. Yoshinaga K; Katoh C; Manabe O; Klein R; Naya M; Sakakibara M; Yamada S; Dekemp RA; Tsutsui H; Tamaki N Circ J; 2011; 75(11):2628-34. PubMed ID: 21873801 [TBL] [Abstract][Full Text] [Related]
36. Automated Motion Correction for Myocardial Blood Flow Measurements and Diagnostic Performance of Kuronuma K; Wei CC; Singh A; Lemley M; Hayes SW; Otaki Y; Hyun MC; Van Kriekinge SD; Kavanagh P; Huang C; Han D; Dey D; Berman DS; Slomka PJ J Nucl Med; 2024 Jan; 65(1):139-146. PubMed ID: 38050106 [TBL] [Abstract][Full Text] [Related]
37. Safety and feasibility of regadenoson use for suboptimal heart rate response during symptom-limited standard Bruce exercise stress test. Partington SL; Lanka V; Hainer J; Blankstein R; Skali H; Forman DE; Di Carli MF; Dorbala S J Nucl Cardiol; 2012 Oct; 19(5):970-8. PubMed ID: 22565239 [TBL] [Abstract][Full Text] [Related]
38. Assessment of transient ischemic dilation (TID) ratio in gated SPECT myocardial perfusion imaging (MPI) using regadenoson, a new agent for pharmacologic stress testing. Katz JS; Ruisi M; Giedd KN; Rachko M J Nucl Cardiol; 2012 Aug; 19(4):727-34. PubMed ID: 22527801 [TBL] [Abstract][Full Text] [Related]
39. Comparison and prognostic validation of multiple methods of quantification of myocardial blood flow with 82Rb PET. Murthy VL; Lee BC; Sitek A; Naya M; Moody J; Polavarapu V; Ficaro EP; Di Carli MF J Nucl Med; 2014 Dec; 55(12):1952-8. PubMed ID: 25429160 [TBL] [Abstract][Full Text] [Related]
40. Initial experience with regadenoson stress positron emission tomography in patients with left bundle branch block: Low prevalence of septal defects and high accuracy for obstructive coronary artery disease. Meredith D; Cremer PC; Harb SC; Xu B; Mentias A; Jaber WA J Nucl Cardiol; 2021 Apr; 28(2):536-542. PubMed ID: 30877551 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]